DCF — SHARP CORONADO HOSPITAL
Enterprise Value: $-94.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-94.4M
Enterprise Value
$-32.8M
PV of Cash Flows
$-61.6M
PV of Terminal Value
$-99.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $145.0M | $-4.3M | -3.0% | $-10.4M | $-9.5M |
| Year 2 | $149.4M | $-2.9M | -2.0% | $-9.3M | $-7.7M |
| Year 3 | $153.8M | $-1.5M | -1.0% | $-8.0M | $-6.0M |
| Year 4 | $158.5M | $-0.7M | -0.0% | $-7.4M | $-5.1M |
| Year 5 | $163.2M | $-0.4M | -0.0% | $-7.3M | $-4.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-94.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$140.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.034674574686289795
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5